201 related articles for article (PubMed ID: 30465671)
41. Unique copper-induced oligomers mediate alpha-synuclein toxicity.
Wright JA; Wang X; Brown DR
FASEB J; 2009 Aug; 23(8):2384-93. PubMed ID: 19325037
[TBL] [Abstract][Full Text] [Related]
42. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.
Cole NB; Murphy DD; Lebowitz J; Di Noto L; Levine RL; Nussbaum RL
J Biol Chem; 2005 Mar; 280(10):9678-90. PubMed ID: 15615715
[TBL] [Abstract][Full Text] [Related]
43. Alpha-synuclein: relating metals to structure, function and inhibition.
McDowall JS; Brown DR
Metallomics; 2016 Apr; 8(4):385-97. PubMed ID: 26864076
[TBL] [Abstract][Full Text] [Related]
44. Acrolein and Copper as Competitive Effectors of α-Synuclein.
Falcone E; Ahmed IMM; Oliveri V; Bellia F; Vileno B; El Khoury Y; Hellwig P; Faller P; Vecchio G
Chemistry; 2020 Feb; 26(8):1871-1879. PubMed ID: 31804737
[TBL] [Abstract][Full Text] [Related]
45. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
Kardani J; Roy I
ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
[TBL] [Abstract][Full Text] [Related]
46. Effect of manganese treatment on the accumulation on biologically relevant metals in rat cochlea and brain by inductively coupled plasma mass spectrometry.
Mullin EJ; Wegst-Uhrich SR; Ding D; Manohar S; Krishnan Muthaiah VP; Salvi R; Aga DS; Roth JA
Biometals; 2015 Dec; 28(6):1009-16. PubMed ID: 26433897
[TBL] [Abstract][Full Text] [Related]
47. Switching on Endogenous Metal Binding Proteins in Parkinson's Disease.
McLeary FA; Rcom-H'cheo-Gauthier AN; Goulding M; Radford RAW; Okita Y; Faller P; Chung RS; Pountney DL
Cells; 2019 Feb; 8(2):. PubMed ID: 30791479
[TBL] [Abstract][Full Text] [Related]
48. Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.
Wang C; Liu L; Zhang L; Peng Y; Zhou F
Biochemistry; 2010 Sep; 49(37):8134-42. PubMed ID: 20701279
[TBL] [Abstract][Full Text] [Related]
49. Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Kang JH; Kim KS
Mol Cells; 2003 Feb; 15(1):87-93. PubMed ID: 12661766
[TBL] [Abstract][Full Text] [Related]
50. Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site.
Blacher C; Abramov-Harpaz K; Miller Y
Biomolecules; 2024 May; 14(6):. PubMed ID: 38927031
[TBL] [Abstract][Full Text] [Related]
51. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
Drew SC
Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
[TBL] [Abstract][Full Text] [Related]
52. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.
Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO
J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689
[TBL] [Abstract][Full Text] [Related]
53. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity.
Xu CK; Castellana-Cruz M; Chen SW; Du Z; Meisl G; Levin A; Mannini B; Itzhaki LS; Knowles TPJ; Dobson CM; Cremades N; Kumita JR
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209093
[TBL] [Abstract][Full Text] [Related]
54. Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
Free Radic Biol Med; 2002 Mar; 32(6):544-50. PubMed ID: 11958955
[TBL] [Abstract][Full Text] [Related]
55. Cu
Ramis R; Ortega-Castro J; Vilanova B; Adrover M; Frau J
Int J Biol Macromol; 2021 Feb; 169():251-263. PubMed ID: 33345970
[TBL] [Abstract][Full Text] [Related]
56. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
[TBL] [Abstract][Full Text] [Related]
57. Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.
McFarland MA; Ellis CE; Markey SP; Nussbaum RL
Mol Cell Proteomics; 2008 Nov; 7(11):2123-37. PubMed ID: 18614564
[TBL] [Abstract][Full Text] [Related]
58. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
59. Characterization of Molecular Tweezer Binding on α-Synuclein with Native Top-Down Mass Spectrometry and Ion Mobility-Mass Spectrometry Reveals a Mechanism for Aggregation Inhibition.
Lantz C; Lopez J; Goring AK; Zenaidee MA; Biggs K; Whitelegge JP; Ogorzalek Loo RR; Klärner FG; Schrader T; Bitan G; Loo JA
J Am Soc Mass Spectrom; 2023 Dec; 34(12):2739-2747. PubMed ID: 37936057
[TBL] [Abstract][Full Text] [Related]
60. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
